Recent epidemiological evidence has shown an increasing trend in the prevalence of hyperuricemia and gout in the Western world: a number of population-based studies estimate a prevalence of up to 21% for hyperuricemia and 1%–4% for gout.
← all excerpts
An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia.
1
—
—